Photo taken from ESMO/X
May 15, 2024, 13:47
Interview with Eric Van Cutsem and Zorana Maravic on the ESMO Daily Reporter – ESMO
The European Society for Medical Oncology (ESMO) shared on X:
“While novel agents continue to enrich the therapeutic armamentarium in mCRC, patients expect not only prolonged survival, but also higher QoL.
Read the interview with Eric Van Cutsem and Zorana Maravic on the ESMO Daily Reporter.”
Source: ESMO/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 22, 2025, 21:34
Aug 22, 2025, 21:01
Aug 22, 2025, 20:48
Aug 22, 2025, 20:36
Aug 22, 2025, 19:34
Aug 22, 2025, 19:17